Australia Adeno-associated Virus Gene Therapy Market Size, Share, Trends and Forecast by Therapeutic Area, Vector Serotype, Route of Administration, Application, Manufacturing Type, End User, and Region, 2026-2034

Report Format: PDF+Excel | Report ID: SR112026A45365

Buy Now

1    Preface
2    Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Australia Adeno-associated Virus Gene Therapy Market - Introduction
    4.1    Overview
    4.2    Market Dynamics
    4.3    Industry Trends
    4.4    Competitive Intelligence
5    Australia Adeno-associated Virus Gene Therapy Market Landscape
    5.1    Historical and Current Market Trends (2020-2025)
    5.2    Market Forecast (2026-2034)
6    Australia Adeno-associated Virus Gene Therapy Market - Breakup by Therapeutic Area/Disease Indication
    6.1    Neurological Disorders
        6.1.1    Overview
        6.1.2    Historical and Current Market Trends (2020-2025)
        6.1.3    Market Segmentation
            6.1.3.1    Spinal Muscular Atrophy (SMA) (e.g., Zolgensma)
            6.1.3.2    Parkinson's Disease
            6.1.3.3    Alzheimer's Disease
            6.1.3.4    Rett Syndrome
            6.1.3.5    Amyotrophic Lateral Sclerosis (ALS)
            6.1.3.6    Canavan Disease
            6.1.3.7    Aromatic L-amino acid decarboxylase (AADC) Deficiency
            6.1.3.8    Huntington's Disease
            6.1.3.9    Friedreich's Ataxia
        6.1.4    Market Forecast (2026-2034)
    6.2    Ophthalmic Disorders
        6.2.1    Overview
        6.2.2    Historical and Current Market Trends (2020-2025)
        6.2.3    Market Segmentation
            6.2.3.1    Leber Congenital Amaurosis (LCA) (e.g., Luxturna)
            6.2.3.2    Retinitis Pigmentosa
            6.2.3.3    Wet Age-related Macular Degeneration (AMD)
            6.2.3.4    Stargardt Disease
            6.2.3.5    Choroideremia
        6.2.4    Market Forecast (2026-2034)
    6.3    Hematologic Disorders
        6.3.1    Overview
        6.3.2    Historical and Current Market Trends (2020-2025)
        6.3.3    Market Segmentation
            6.3.3.1    Hemophilia A (e.g., Roctavian)
            6.3.3.2    Hemophilia B (e.g., Hemgenix)
            6.3.3.3    Thalassemia
            6.3.3.4    Sickle Cell Disease
        6.3.4    Market Forecast (2026-2034)
    6.4    Muscular Disorders
        6.4.1    Overview
        6.4.2    Historical and Current Market Trends (2020-2025)
        6.4.3    Market Segmentation
            6.4.3.1    Duchenne Muscular Dystrophy (DMD) (e.g., Elevidys)
            6.4.3.2    Limb-Girdle Muscular Dystrophy (LGMD)
        6.4.4    Market Forecast (2026-2034)
    6.5    Metabolic Disorders
        6.5.1    Overview
        6.5.2    Historical and Current Market Trends (2020-2025)
        6.5.3    Market Segmentation
            6.5.3.1    Alpha-1 Antitrypsin Deficiency
            6.5.3.2    Phenylketonuria (PKU)
            6.5.3.3    Glycogen Storage Diseases
            6.5.3.4    Hereditary Lipoprotein Lipase Deficiency (LPLD) (e.g., Glybera - though withdrawn)
        6.5.4    Market Forecast (2026-2034)
    6.6    Rare Genetic Disorders (Other)
        6.6.1    Overview
        6.6.2    Historical and Current Market Trends (2020-2025)
        6.6.3    Market Segmentation
            6.6.3.1    Mucopolysaccharidosis (MPS)
            6.6.3.2    Batten Disease
            6.6.3.3    Cystic Fibrosis
            6.6.3.4    Sanfilippo Syndrome
        6.6.4    Market Forecast (2026-2034)
    6.7    Oncology/Cancer
        6.7.1    Overview
        6.7.2    Historical and Current Market Trends (2020-2025)
        6.7.3    Market Segmentation
            6.7.3.1    Various cancer types where AAVs are used for targeted delivery of anti-cancer genes.
            6.7.3.2    Cardiovascular Diseases
        6.7.4    Market Forecast (2026-2034)
7    Australia Adeno-associated Virus Gene Therapy Market - Breakup by Vector Serotype
    7.1    AAV1
        7.1.1    Overview
        7.1.2    Historical and Current Market Trends (2020-2025)
        7.1.3    Market Forecast (2026-2034)
    7.2    AAV2
        7.2.1    Overview
        7.2.2    Historical and Current Market Trends (2020-2025)
        7.2.3    Market Forecast (2026-2034)
    7.3    AAV3
        7.3.1    Overview
        7.3.2    Historical and Current Market Trends (2020-2025)
        7.3.3    Market Forecast (2026-2034)
    7.4    AAV4
        7.4.1    Overview
        7.4.2    Historical and Current Market Trends (2020-2025)
        7.4.3    Market Forecast (2026-2034)
    7.5    AAV5
        7.5.1    Overview
        7.5.2    Historical and Current Market Trends (2020-2025)
        7.5.3    Market Forecast (2026-2034)
    7.6    AAV6
        7.6.1    Overview
        7.6.2    Historical and Current Market Trends (2020-2025)
        7.6.3    Market Forecast (2026-2034)
    7.7    AAV7
        7.7.1    Overview
        7.7.2    Historical and Current Market Trends (2020-2025)
        7.7.3    Market Forecast (2026-2034)
    7.8    AAV8
        7.8.1    Overview
        7.8.2    Historical and Current Market Trends (2020-2025)
        7.8.3    Market Forecast (2026-2034)
    7.9    AAV9
        7.9.1    Overview
        7.9.2    Historical and Current Market Trends (2020-2025)
        7.9.3    Market Forecast (2026-2034)
    7.10    AAV10
        7.10.1    Overview
        7.10.2    Historical and Current Market Trends (2020-2025)
        7.10.3    Market Forecast (2026-2034)
    7.11    AAV11
        7.11.1    Overview
        7.11.2    Historical and Current Market Trends (2020-2025)
        7.11.3    Market Forecast (2026-2034)
    7.12    AAV12
        7.12.1    Overview
        7.12.2    Historical and Current Market Trends (2020-2025)
        7.12.3    Market Forecast (2026-2034)
    7.13    Engineered/Synthetic/Hybrid Capsids
        7.13.1    Overview
        7.13.2    Historical and Current Market Trends (2020-2025)
        7.13.3    Market Forecast (2026-2034)
8    Australia Adeno-associated Virus Gene Therapy Market - Breakup by Route of Administration
    8.1    Intravenous (I.V.)
        8.1.1    Overview
        8.1.2    Historical and Current Market Trends (2020-2025)
        8.1.3    Market Forecast (2026-2034)
    8.2    Intrathecal (I.T.) (for CNS delivery)
        8.2.1    Overview
        8.2.2    Historical and Current Market Trends (2020-2025)
        8.2.3    Market Forecast (2026-2034)
    8.3    Intraocular (I.O.) (e.g., intravitreal, subretinal)
        8.3.1    Overview
        8.3.2    Historical and Current Market Trends (2020-2025)
        8.3.3    Market Forecast (2026-2034)
    8.4    Intramuscular (I.M.)
        8.4.1    Overview
        8.4.2    Historical and Current Market Trends (2020-2025)
        8.4.3    Market Forecast (2026-2034)
    8.5    Intracerebral
        8.5.1    Overview
        8.5.2    Historical and Current Market Trends (2020-2025)
        8.5.3    Market Forecast (2026-2034)
    8.6    Subcutaneous
        8.6.1    Overview
        8.6.2    Historical and Current Market Trends (2020-2025)
        8.6.3    Market Forecast (2026-2034)
    8.7    Local/Direct Injection (e.g., into specific organs)
        8.7.1    Overview
        8.7.2    Historical and Current Market Trends (2020-2025)
        8.7.3    Market Forecast (2026-2034)
9    Australia Adeno-associated Virus Gene Therapy Market - Breakup by Application
    9.1    Preclinical Therapies
        9.1.1    Overview
        9.1.2    Historical and Current Market Trends (2020-2025)
        9.1.3    Market Forecast (2026-2034)
    9.2    Clinical Therapies
        9.2.1    Overview
        9.2.2    Historical and Current Market Trends (2020-2025)
        9.2.3    Market Forecast (2026-2034)
    9.3    Commercialized Therapies
        9.3.1    Overview
        9.3.2    Historical and Current Market Trends (2020-2025)
        9.3.3    Market Forecast (2026-2034)
10    Australia Adeno-associated Virus Gene Therapy Market - Breakup by Manufacturing Type
    10.1    In-house Manufacturing
        10.1.1    Overview
        10.1.2    Historical and Current Market Trends (2020-2025)
        10.1.3    Market Forecast (2026-2034)
    10.2    CDMOs/Vector Production Facilities
        10.2.1    Overview
        10.2.2    Historical and Current Market Trends (2020-2025)
        10.2.3    Market Forecast (2026-2034)
11    Australia Adeno-associated Virus Gene Therapy Market - Breakup by End User
    11.1    Pharmaceutical and Biotechnology Companies
        11.1.1    Overview
        11.1.2    Historical and Current Market Trends (2020-2025)
        11.1.3    Market Forecast (2026-2034)
    11.2    Academic and Research Institutes
        11.2.1    Overview
        11.2.2    Historical and Current Market Trends (2020-2025)
        11.2.3    Market Forecast (2026-2034)
    11.3    Contract Research Organizations (CROs)
        11.3.1    Overview
        11.3.2    Historical and Current Market Trends (2020-2025)
        11.3.3    Market Forecast (2026-2034)
12    Australia Adeno-associated Virus Gene Therapy Market - Breakup by Region
    12.1    Australia Capital Territory & New South Wales
        12.1.1    Overview
        12.1.2    Historical and Current Market Trends (2020-2025)
        12.1.3    Market Breakup by Therapeutic Area/Disease Indication
        12.1.4    Market Breakup by Vector Serotype
        12.1.5    Market Breakup by Route of Administration
        12.1.6    Market Breakup by Application
        12.1.7    Market Breakup by Manufacturing Type
        12.1.8    Market Breakup by End User
        12.1.9    Key Players
        12.1.10    Market Forecast (2026-2034)
    12.2    Victoria & Tasmania
        12.2.1    Overview
        12.2.2    Historical and Current Market Trends (2020-2025)
        12.2.3    Market Breakup by Therapeutic Area/Disease Indication
        12.2.4    Market Breakup by Vector Serotype
        12.2.5    Market Breakup by Route of Administration
        12.2.6    Market Breakup by Application
        12.2.7    Market Breakup by Manufacturing Type
        12.2.8    Market Breakup by End User
        12.2.9    Key Players
        12.2.10    Market Forecast (2026-2034)
    12.3    Queensland
        12.3.1    Overview
        12.3.2    Historical and Current Market Trends (2020-2025)
        12.3.3    Market Breakup by Therapeutic Area/Disease Indication
        12.3.4    Market Breakup by Vector Serotype
        12.3.5    Market Breakup by Route of Administration
        12.3.6    Market Breakup by Application
        12.3.7    Market Breakup by Manufacturing Type
        12.3.8    Market Breakup by End User
        12.3.9    Key Players
        12.3.10    Market Forecast (2026-2034)
    12.4    Northern Territory & Southern Australia
        12.4.1    Overview
        12.4.2    Historical and Current Market Trends (2020-2025)
        12.4.3    Market Breakup by Therapeutic Area/Disease Indication
        12.4.4    Market Breakup by Vector Serotype
        12.4.5    Market Breakup by Route of Administration
        12.4.6    Market Breakup by Application
        12.4.7    Market Breakup by Manufacturing Type
        12.4.8    Market Breakup by End User
        12.4.9    Key Players
        12.4.10    Market Forecast (2026-2034)
    12.5    Western Australia
        12.5.1    Overview
        12.5.2    Historical and Current Market Trends (2020-2025)
        12.5.3    Market Breakup by Therapeutic Area/Disease Indication
        12.5.4    Market Breakup by Vector Serotype
        12.5.5    Market Breakup by Route of Administration
        12.5.6    Market Breakup by Application
        12.5.7    Market Breakup by Manufacturing Type
        12.5.8    Market Breakup by End User
        12.5.9    Key Players
        12.5.10    Market Forecast (2026-2034)
13    Australia Adeno-associated Virus Gene Therapy Market - Competitive Landscape
    13.1    Overview
    13.2    Market Structure
    13.3    Market Player Positioning
    13.4    Top Winning Strategies
    13.5    Competitive Dashboard
    13.6    Company Evaluation Quadrant
14    Profiles of Key Players
    14.1    Company A
        14.1.1    Business Overview
        14.1.2    Products Offered
        14.1.3    Business Strategies
        14.1.4    SWOT Analysis
        14.1.5    Major News and Events
    14.2    Company B
        14.2.1    Business Overview
        14.2.2    Products Offered
        14.2.3    Business Strategies
        14.2.4    SWOT Analysis
        14.2.5    Major News and Events
    14.3    Company C
        14.3.1    Business Overview
        14.3.2    Products Offered
        14.3.3    Business Strategies
        14.3.4    SWOT Analysis
        14.3.5    Major News and Events
    14.4    Company D
        14.4.1    Business Overview
        14.4.2    Products Offered
        14.4.3    Business Strategies
        14.4.4    SWOT Analysis
        14.4.5    Major News and Events
    14.5    Company E
        14.5.1    Business Overview
        14.5.2    Products Offered
        14.5.3    Business Strategies
        14.5.4    SWOT Analysis
        14.5.5    Major News and Events

Company names have not been provided here as this is a sample TOC. The complete list is provided in the report.

15    Australia Adeno-associated Virus Gene Therapy Market - Industry Analysis
    15.1    Drivers, Restraints, and Opportunities
        15.1.1    Overview
        15.1.2    Drivers
        15.1.3    Restraints
        15.1.4    Opportunities
    15.2    Porters Five Forces Analysis
        15.2.1    Overview
        15.2.2    Bargaining Power of Buyers
        15.2.3    Bargaining Power of Suppliers
        15.2.4    Degree of Competition
        15.2.5    Threat of New Entrants
        15.2.6    Threat of Substitutes
    15.3    Value Chain Analysis
16    Appendix

Purchase Options Discount
Offer

Request Customization

Speak to an Analyst

Request Brochure

Inquire Before Buying

Benefits of Customization

Personalize this research
Triangulate with your data
Get data as per your format and definition
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-201-971-6302

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

IMARC did an outstanding job in preparing our study. They were punctual and precise, delivering all the data we required in a clear and well-organized format. Their attention to detail and ability to meet deadlines was impressive, making them a reliable partner for our project.

I wanted to express my sincere appreciation for your efforts in handling this matter. Your dedication and commitment have truly been commendable. It is evident that you have put in a tremendous amount of hard work and expertise into resolving the issues at hand. I would also like to take this opportunity to inform you that we are greatly interested

Overall, the deliverable was well organized and my experience with the project team was good. In particular, I appreciated how they responded when I requested additional information and the Japanese version.

The IMARC team were extremely professional and very cooperative. The team were also extremely flexible in making changes and modifications wherever required. The entire experience right from project kick-off to after sales support was fruitful and smooth.

I’d like to express my gratitude for the work you accomplished with the industry report. The way you responded to the requirements and delivered under tight timelines shows your expertise, exceptional work ethic and commitment to your customer’s success. The entire team and company are incredibly thankful for your dedication. Once again, thank you

The market reports from IMARC have been instrumental in guiding our business strategies. We found the reports comprehensive and data-driven, which helped us make informed decisions. The detailed insights and actionable data have consistently provided us with a competitive edge in a rapidly changing alcohol market.

One of the best things about IMARC is their flexibility and predisposition to tailor the reports and adapt to our needs. They are not just great in their researching and consulting solutions, but their service is unparallelled. We’ve worked with them a couple of times and we will keep working with them in future projects.

We recently commissioned multiple market research reports from IMARC, and the insights we received were invaluable. The depth of analysis, accuracy of data, and actionable recommendations have greatly enhanced our strategic decision-making.

The market estimates provided by your team were pretty much in line with what we were theorizing internally. Really appreciate the work on this.

The sale account manager and the service was excellent. The data and market trends gathered from the report was insightful and really assisted while planning future product and growth strategies.

The report is excellent and has good amount of data and our team is extremely happy with the information provided.

Thank you very much for your cooperation and post purchase support. We were really happy with the final deliverable, and the takeaways from the report.